IC
CERE

Ikarian Capital’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History

Ikarian Capital’s Portfolio CERE Stock Details CERE Fund Activity
Quarter Market Value Status Shares Shares
Change % 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-178,100
Closed -$5.03M – 84
2022
Q3 		$5.03M Buy
+178,100
New +$5.03M 1% 16
2021
Q4 		– Sell
-53,370
Closed -$1.57M – 189
2021
Q3 		$1.57M Buy
+53,370
New +$1.57M 0.11% 78